Tesaro Announces Participation in Two Investor Conferences
April 25 2017 - 4:15PM
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical
company, today announced its participation in two upcoming investor
conferences. The two conferences are:
- The Leerink Boston Biopharma Bus Tour on Wednesday, May
10, 2017. Lonnie Moulder, CEO, Mary Lynne Hedley, Ph.D.,
President and COO, and Tim Pearson, EVP and CFO of TESARO, will
present at 1:00 PM ET and will answer questions from
investors.
- The Bank of America Merrill Lynch 2017 Healthcare
Conference at the Loews Hotel in Las Vegas, Nevada on Wednesday,
May 17, 2017. Tim Pearson will participate in an
analyst-led moderated Q&A at 3:00 PM PT and in meetings with
investors.
A live
webcast of the presentation at the Bank of America conference will
be available by visiting the Investors section of the TESARO
website at www.tesarobio.com. An archived replay of this webcast
will be available on the Company’s website for 14 days following
the conferences.
About TESAROTESARO is an
oncology-focused biopharmaceutical company devoted to providing
transformative therapies to people bravely facing cancer. For more
information, visit www.tesarobio.com, and follow us on Twitter and
LinkedIn.
For additional information, please contact:
Jennifer Davis
1.781.325.1116
jdavis@tesarobio.com
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Apr 2023 to Apr 2024